Propylpyrazoletriol

Propylpyrazoletriol (also known as PPT) is a synthetic steroid that acts as a selective estrogen receptor modulator (SERM). It is specifically an agonist of the estrogen receptor (ER) α, with 400 times selectivity over ERβ.

Pharmacology

Propylpyrazoletriol is a synthetic steroid that acts as a selective estrogen receptor modulator. It is an agonist of the estrogen receptor α, with 400 times selectivity over ERβ. This means that it has the ability to bind to and activate this receptor, but not others. This selectivity can be beneficial in certain medical conditions where activation of only certain estrogen receptors is desired.

Medical Uses

While Propylpyrazoletriol is not currently used in medical practice, its unique properties make it a subject of interest for research. Its high selectivity for ERα over ERβ could potentially be exploited for therapeutic benefit in conditions where selective activation of this receptor is beneficial.

Research

Research into the potential uses of Propylpyrazoletriol is ongoing. Its high selectivity for ERα over ERβ is of particular interest, as this could potentially be exploited for therapeutic benefit in certain conditions. However, more research is needed to fully understand the potential benefits and risks of this compound.

See Also

• Selective estrogen receptor modulator
• Estrogen receptor
• Agonist
• Synthetic steroid

Propylpyrazoletriol Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski